Evidence map›Paper›PMID 25339762›Full record

ArticleJournal of virology2015

Identification of residues in the human respiratory syncytial virus fusion protein that modulate fusion activity and pathogenesis.

Anne L Hotard, Sujin Lee, Michael G Currier, James E Crowe, Kaori Sakamoto, Dawn C Newcomb, R Stokes Peebles, Richard K Plemper, Martin L Moore

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Respiratory Syncytial Virus Fusion Activity Syncytia Assay.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Anne L HotardDepartment of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
Sujin LeeDepartment of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
Michael G CurrierDepartment of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
James E CroweDepartment of Pathology, Microbiology and Immunology, Vanderbilt Medical Center, Nashville, Tennessee, USA Department of Pediatrics, Vanderbilt Medical Center, Nashville, Tennessee, USA The Vanderbilt Vaccine Center of Vanderbilt Medical Center, Nashville, Tennessee, USA.
Kaori SakamotoDepartment of Pathology, College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA.
Dawn C NewcombDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, Tennesee, USA.
R Stokes PeeblesDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, Tennesee, USA.
Richard K PlemperInstitute for Biomedical Sciences, Georgia State University, Atlanta, Georgia, USA.
Martin L MooreDepartment of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA Children's Healthcare of Atlanta, Atlanta, Georgia, USA martin.moore@emory.edu.
Children's Healthcare of Atlanta · USEmory University · USVanderbilt University · USGeorgia State University · USUniversity of Georgia · USVanderbilt University Medical Center · US

Funding

Viral and Host Determinants of Infant and Childhood Allergy and AsthmaU19AI095227 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Dawn C Newcomb · 2011 to 2026
$34.9M
Building Interdisciplinary Research Careers in Women's HealthK12HD043483 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HARTMANN, KATHERINE E, MAJOR, AMY S · 2002 to 2023
$10.3M
Identification and Pre-Clinical Evaluation of Measles Virus InhibitorsR01AI071002 · NIAID · GEORGIA STATE UNIVERSITY · PI PLEMPER, RICHARD K. · 2006 to 2022
$6.6M
Immunobiology of Blood and Vascular Systems Training ProgramT32HL069765 · NHLBI · VANDERBILT UNIVERSITY · PI HAWIGER, JACK J · 2002 to 2016
$6.5M
Novel Therapeutics against Respiratory Syncytial Virus InfectionR01HD079327 · NICHD · GEORGIA STATE UNIVERSITY · PI PLEMPER, RICHARD K. · 2014 to 2018
$2.8M
Role of the Respiratory Syncytial Virus Fusion Protein in Airway Mucus InductionR01AI087798 · NIAID · EMORY UNIVERSITY · PI MOORE, MARTIN LAWRENCE · 2010 to 2014
$1.9M
Cryo-Electron and Biochemical Anaysis of Native Paramyxovirus Fusion ComplexesR01AI083402 · NIAID · GEORGIA STATE UNIVERSITY · PI PLEMPER, RICHARD K. · 2011 to 2015
$1.7M
Cryo-Electron and Biochemical Analysis of Native Paramyxovirus Fusion ComplexesR56AI083402 · NIAID · EMORY UNIVERSITY · PI PLEMPER, RICHARD K. · 2010 to 2010
$380k
NHLBI NIH HHS T32 HL069765NIAID NIH HHS 1R01AI087798NIAID NIH HHS 1U19AI095227NIAID NIH HHS AI083402NIAID NIH HHS R01 AI071002NIAID NIH HHS R01 AI083402NIAID NIH HHS R01 AI087798NIAID NIH HHS R56 AI083402NIAID NIH HHS U19 AI095227NICHD NIH HHS K12 HD043483NICHD NIH HHS R01 HD079327
6 · The paper itself

Abstract

unlabelledHuman respiratory syncytial virus (RSV) lower respiratory tract infection can result in inflammation and mucus plugging of airways. RSV strain A2-line19F induces relatively high viral load and mucus in mice. The line 19 fusion (F) protein harbors five unique residues compared to the non-mucus-inducing strains A2 and Long, at positions 79, 191, 357, 371, and 557. We hypothesized that differential fusion activity is a determinant of pathogenesis. In a cell-cell fusion assay, line 19 F was more fusogenic than Long F. We changed the residues unique to line 19 F to the corresponding residues in Long F and identified residues 79 and 191 together as responsible for high fusion activity. Surprisingly, mutation of residues 357 or 357 with 371 resulted in gain of fusion activity. Thus, we generated RSV F mutants with a range of defined fusion activity and engineered these into recombinant viruses. We found a clear, positive correlation between fusion activity and early viral load in mice; however, we did not detect a correlation between viral loads and levels of airway mucin expression. The F mutant with the highest fusion activity, A2-line19F-K357T/Y371N, induced high viral loads, severe lung histopathology, and weight loss but did not induce high levels of airway mucin expression. We defined residues 79/191 as critical for line 19 F fusion activity and 357/371 as playing a role in A2-line19F mucus induction. Defining the molecular basis of the role of RSV F in pathogenesis may aid vaccine and therapeutic strategies aimed at this protein. IMPORTANCE: Human respiratory syncytial virus (RSV) is the most important lower respiratory tract pathogen of infants for which there is no vaccine. Elucidating mechanisms of RSV pathogenesis is important for rational vaccine and drug design. We defined specific amino acids in the fusion (F) protein of RSV strain line 19 critical for fusion activity and elucidated a correlation between fusion activity and viral load in mice. Further, we identified two distinct amino acids in F as contributing to the mucogenic phenotype of the A2-line19F virus. Taken together, these results illustrate a role for RSV F in virulence.

Indexed as

Virus InternalizationAnimalsCell LineDisease Models, AnimalDNA Mutational AnalysisFemaleHistocytochemistryHumansLungMice, Inbred BALB CRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsViral Fusion ProteinsViral LoadWeight LossF protein, human respiratory syncytial virusViral Fusion Proteins

Identifiers

PMID25339762
PMCPMC4301159
OpenAlexW2073045612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.